China Resources Boya Bio-pharmaceutical Issues Sharp 2025 Profit Warning
China Resources Boya Bio-pharmaceutical, a key player in blood products and medical aesthetics, has issued a stark profit warning for 2025, forecasting net profit attributable to shareholders at
